|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/12 | |||
| A61K 47/26 | |||
| C07K 16/24 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2331078 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09791868.4 |
| Europos patento paraiškos padavimo data | 2009-08-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/054842 |
| Data | 2009-08-25 |
| (87) | Numeris | WO 2010/027766 |
| Data | 2010-03-11 |
| (30) | Numeris | Data | Šalis |
| 92326 P | 2008-08-27 | US |
| (72) |
LI, Xuhong, US
KASHI, Ramesh, S., US
BADKAR, Aniket, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | LYOPHILIZED FORMULATIONS OF ENGINEERED ANTI-IL-23P19 ANTIBODIES |
| LYOPHILIZED FORMULATIONS OF ENGINEERED ANTI-IL-23P19 ANTIBODIES |